Last updated July 2026. Updated to reflect Peec AI data on AI Overview trigger rates for commercial health queries and Profound citation-source research for drug-comparison prompts.
Healthcare is one of the highest AI-trigger verticals in search. Studies consistently find AI Overviews appearing on a large majority of health-related queries. For drug-comparison searches, that figure is higher still: the combination of “versus,” “vs,” mechanism-of-action language, and dosing questions almost guarantees a generative answer appears at the top of the page.
Pharma brands are largely absent from those answers.
Not because the content does not exist. Because the content is in the wrong format, on the wrong domains, and structured in a way that makes it hard for retrieval systems to extract a clean, citable passage.
This playbook is for the teams trying to fix that.
What AI engines actually do when a drug-comparison query arrives
Before optimizing for citations, it helps to understand the retrieval pattern.
When a user asks “metformin vs semaglutide for type 2 diabetes weight loss,” a generative engine runs a set of sub-queries against its index. It is not looking for promotional content. It is looking for sources it treats as authoritative: peer-reviewed abstracts, clinical summary pages, formulary databases, and established medical publishers.
The well-documented pattern across ChatGPT, Perplexity, and Google AI Overviews is consistent:
- PubMed abstracts appear when a query touches mechanism of action, clinical trial results, or comparative efficacy data.
- Mayo Clinic and WebMD disease summary pages appear for condition-level and patient-facing comparison queries.
- MedlinePlus and Drugs.com appear for patient-accessible monograph-style content.
- UpToDate and Epocrates appear for HCP-facing dosing and interaction queries where those platforms are crawlable.
- Medical society guidelines (AHA, ADA, NCCN, ACOG) appear for treatment-algorithm queries.
- Brand pages almost never appear unless they are published on an HCP portal or medical-affairs domain with non-promotional framing and structured clinical data.
The practical consequence: a pharma brand that publishes only traditional promotional materials has zero GEO surface area for drug-comparison queries. The content exists. The engines ignore it.
Step 1: Build your source-attribution table
The first step is not content creation. It is a structured observation exercise.
A source-attribution table maps the domains AI engines actually cite for your target queries. It becomes both a GEO strategy brief and a compliance audit document.
Here is the structure to use:
| Target query | Engine tested | Cited domain | Page type | Passage lifted | Compliance status |
|---|---|---|---|---|---|
| ”[Drug A] vs [Drug B] side effects” | ChatGPT | pubmed.ncbi.nlm.nih.gov | Abstract | Exact paragraph from Methods | N/A (third party) |
| “[Drug A] vs [Drug B] side effects” | Perplexity | mayoclinic.org | Disease summary | First 3 sentences of summary | N/A (third party) |
| “[Drug A] dosing renal impairment” | Google AI Overview | drugs.com | Monograph | Dosing table row | N/A (third party) |
| “[Drug A] mechanism of action” | ChatGPT | yourmedicalaffairs.com | HCP portal | (not cited) | Pending review |
Run your 10 to 20 highest-priority queries across at least two engines. Record every cited domain and, where possible, identify the specific passage the engine lifted. That passage is the content unit you are competing against.
Tools that surface citation-source URLs directly include Profound (citation maps showing exact URLs per query), Peec AI (query-level citation patterns at scale), and Semrush (AI Overview coverage for health keywords). Temso covers eight engines in one subscription and flags citation gaps that can feed a content or earned-media brief.
Step 2: Understand the passage structure engines prefer
Once you know which domains engines cite, look at what they are actually lifting from those pages.
The pattern across PubMed, Mayo Clinic, and WebMD is consistent. The passages engines extract share a structure:
Subject + Claim + Metric + Source + Year
A PubMed abstract sentence that gets cited looks like this:
Semaglutide 2.4 mg weekly produced mean body-weight reduction of 14.9% versus 2.4% with placebo at 68 weeks in adults with obesity or overweight (STEP 1 trial, Wilding et al., New England Journal of Medicine, 2021).
Every element is present: the subject (semaglutide 2.4 mg), the claim (body-weight reduction), the metric (14.9% vs 2.4%), the source (STEP 1 trial, NEJM), and the year (2021).
Mayo Clinic summary sentences work the same way, just in plain language:
Metformin lowers blood sugar by reducing glucose production in the liver and improving insulin sensitivity; it does not cause weight gain and is recommended as first-line therapy for type 2 diabetes by the American Diabetes Association (ADA Standards of Medical Care, 2025).
Subject, claim, mechanism detail, safety note, source, year.
Why this matters for GEO: A passage that contains all five elements can be reproduced verbatim by an AI engine without paraphrasing. Paraphrase introduces error. Engines prefer passages they can lift cleanly. A passage missing the metric or the source year is harder to lift without modification, which reduces the chance it gets cited at all.
The 40 to 60 word constraint is practical. It is long enough to include all five elements and short enough to fit within the extraction window that retrieval systems prefer. Research on ChatGPT citation behavior (Kevin Indig, 2026, reported by Search Engine Land) found that 44.2% of citations are drawn from the first 30% of a page’s content. Front-loading compliant, structured passages is not optional. It is the mechanism.
Step 3: Match your content to the citation pattern
The source-attribution table tells you which domains engines cite. The passage structure tells you what those pages contain. Step 3 is aligning your content to both.
This does not mean duplicating third-party content. It means publishing content, on the right domains and in the right format, that gives engines a compliant brand-affiliated passage to cite alongside or instead of the current results.
Where to publish
Medical-affairs or HCP portals. A non-promotional HCP portal is the most direct brand-affiliated surface. Content published there can include clinical trial data, dosing information, and mechanism-of-action summaries without triggering promotional review requirements, provided it is balanced and factually accurate.
Peer-reviewed publication. The most authoritative citation surface is a PubMed-indexed journal entry. Publication strategy is a medical-affairs and scientific communications function, not a marketing one. But the GEO implication is direct: a peer-reviewed abstract that appears in PubMed will be cited by AI engines. A promotional white paper published on the brand website will not.
Disease-state education pages. Patient-facing disease-state education is generally permissible without promotional review when it is free of branded claims. These pages can earn citations for condition-level queries even when the drug itself is not named.
Earned placement in trusted third-party domains. If engines already cite Mayo Clinic, WebMD, or MedlinePlus for your target queries, a brand-funded or company-authored article submitted to those platforms through appropriate channels (licensed content partnerships, expert contributions, or press releases that seed editorial coverage) can earn citations on brand-controlled content placed in brand-independent domains. This is the same earned-media strategy that lifts citation rates in other industries, applied to the specific domains pharma engines trust.
What to write
Every passage on an HCP portal or disease-state page should follow the Subject + Claim + Metric + Source + Year structure. Write it at the top of the page, in the first 30% of content, not buried in a footnote or appendix.
A compliant example for an HCP portal:
Drug A reduced HbA1c by a mean 1.8 percentage points versus 0.9 for Drug B at 26 weeks in patients with type 2 diabetes inadequately controlled on metformin monotherapy (TRAILHEAD-3 trial, Smith et al., Diabetes Care, 2024). Both arms showed comparable cardiovascular safety profiles.
Subject: Drug A. Claim: HbA1c reduction. Metric: 1.8 pp vs 0.9 pp. Source: named trial and journal. Year: 2024. Fair balance is included (cardiovascular safety statement).
Step 4: Update the source-attribution table monthly
GEO in pharma is not a one-time content audit. AI engines re-index sources as new research is published. A PubMed abstract from a new trial can displace your existing citation overnight. A formulary database update can change which dosing comparison appears in an AI Overview.
The source-attribution table becomes a living document when updated monthly.
Run the same query set each month. Record any new cited domains. Flag any passages that have changed. When a new third-party source appears, your compliance team can review whether it accurately represents your drug, and your medical-affairs team can decide whether to publish a response or update.
This is the GEO-native version of competitive monitoring. In traditional SEO, you track which keywords competitors rank for. In pharma GEO, you track which domains AI engines are pulling from for your drug’s queries, and whether those passages are accurate.
The four tools pharma teams use for this workflow
No single tool does everything. Here is where each one fits:
| Tool | Best use in this workflow | Pricing (as of July 2026) |
|---|---|---|
| Profound | Citation maps: exact URLs cited per query, updated across 9+ engines | $99/mo (ChatGPT only); $399/mo full coverage |
| Peec AI | Query-level citation monitoring at scale for health keywords | Self-serve tiers; contact for pharma-specific plans |
| Semrush | AI Overview keyword coverage for health category queries | Included in Semrush Pro and above |
| Temso | Eight-engine citation gap monitoring in one subscription | From $89/mo |
Profound is the most granular for source attribution: its citation maps show exactly which URL an AI engine pulled for a specific prompt, which is the primary input for the source-attribution table. Peec AI is strong for volume monitoring across hundreds of drug-comparison queries. Semrush is useful for identifying AI Overview presence rates before investing in content. Temso covers the broadest engine set and surfaces gaps across eight platforms in a single view, useful for teams that need to monitor across ChatGPT, Google AI Overviews, Perplexity, and Gemini simultaneously without logging into separate tools.
None of these tools replaces a regulatory review of the content itself. The tool tells you what the engine is citing. The compliance review tells you whether your response is appropriate to publish.
The compliance advantage hidden in GEO structure
The 40 to 60 word Subject + Claim + Metric + Source + Year passage format is useful for GEO. It is also useful for compliance.
A passage that contains all five elements is auditable in a way that a long-form article is not. Regulatory affairs teams can review a table of 20 structured passages in the time it takes to review one marketing brochure. The metric is attributed to a named source. The year anchors the claim to a specific evidence base. The subject identifies exactly which drug or condition is being described.
When AI engines cite that passage, the cited claim is traceable back to a specific document with a known regulatory status.
That traceability is not a side effect of good GEO practice. It is the same property that makes content both retrieval-friendly and compliance-auditable. Passages that AI engines prefer to cite are, almost by definition, passages that compliance teams can verify.
What to do first
- Run your 10 highest-priority drug-comparison queries across ChatGPT and Perplexity. Record every cited domain.
- Build the source-attribution table with the five columns above.
- Identify the gaps: queries where your drug is discussed but your brand content is not cited.
- Write three structured passages for your highest-gap query, following the Subject + Claim + Metric + Source + Year format.
- Publish those passages on your HCP portal or medical-affairs site, front-loaded in the page.
- Set a monthly reminder to re-run the queries and update the table.
The full GEO tool comparison that supports this workflow is at /rankings/geo-tools. Definitions for citation share, share of model, and AI Overview are at the /glossary. Scoring criteria for how these tools are evaluated are at /methodology.
To see how Profound, Temso, and Peec AI compare specifically for healthcare citation monitoring, start with the source-attribution exercise above. The tool you choose should be able to answer one question: which specific URL did this AI engine cite for this drug-comparison query? If it cannot answer that, it cannot support the compliance use case.